Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Stinker

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Jul 23, 2024 1:09pm

50 Views

Post# 36144575

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Stinker

That's right...when the Dems lose an election they always blame somebody for tampering, and when they win, they instantly go after anyone who dares to suggest there was any tampering....

Kamala's greatestest accomplishment so far has been to assist in the big 3 1/2 year lie to the American people and cover-up of Biden's cognitive decline....other than that, as you said, the list is very short

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023